Life Science Translation

Before the successful market launch of a new drug or medical device for treating some difficult or chronic disease like cancer, diabetes, stroke, heart-attack, senile dementia or chronic obstructive pulmonary disease (COPD), etc. pharmaceutical companies, need to have it tested on patients/subjects via contract research organizations (CROs) to understand its medical effects and side effects. As trials may take place in many countries, pharmaceutical companies and CROs are seeking more efficient approaches to linguistic validation and clinical trial translation services in order to make the study documents culturally relevant, conceptually equivalent to the source content and acceptable to the target population.

With highly specialized bilingual talents dedicated to incomparable linguistic validation and clinical trial translation service, Raffles Translation has, since 2000, partnered with a number of pharmaceutical companies and CROs to translate forward and backward, in compliance with international regulatory language requirements, their pharmaceutical/clinical trial documents from English to all major Asian languages including simplified Chinese, traditional Chinese, Japanese, Malay, Indonesian, Tamil, Tagalog, Thai, Vietnamese, Korean, Bengali, etc. so as to justify the linguistic validation.